Aerie Pharmaceuticals reported $204.69M in Debt for its third fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Adamas Pharmaceuticals ADMS:US $ 129.96M 0.16M
Antares Pharma ATRS:US $ 40.77M 0.13M
Flexion Therapeutics FLXN:US $ 221.05M 2.6M
Gw Pharmaceuticals GWPH:US $ 14.64M 0.43M
JAZZ PHA JAZZ:US $ 2094.84M 7.15M
Mirati Therapeutics MRTX:US $ 0M 0M
Ophthotech OPHT:US $ 0M 0M
Regeneron Pharmaceuticals REGN:US $ 2695.7M 0.9M
Revance Therapeutics RVNC:US $ 180.53M 3.15M
Teva Pharmaceutical Industries TEVA:US $ 3188M 22433M
Valeant Pharmaceuticals VRX:CN $ 23925M 418M
Zoetis ZTS:US $ 7199M 497M